The coronavirus pandemic has drastically changed the way patients prefer to receive health care – from virtual appointments to delayed treatments. Vice President Janardhan Vellore outlines in Pharmaceutical Executive how biopharmaceutical companies can reinvent the hub to improve patient access and engagement.
Read Full Article